Dr.Sarma`S Laboratories Private Limited
Founded in 1996 and headquartered in Tamil Nadu, India.
1996 | Chennai, Tamil Nadu (India) | Active
Dr.Sarma`S Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 28 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.15 M
About Dr.Sarma`S Laboratories
Dr.Sarma`S Laboratories Private Limited (DLPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 April 1996 and has a history of 28 years and ten months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹0.15 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Parvathy Sarma, Sobana Balakrishnan, and Kootala Balakrishnan serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24131TN1996PTC035241
- Company No.
035241
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 1996
- Date of AGM
09 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Chemicals
Who are the key members and board of directors at Dr.Sarma`S Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parvathy Sarma  | Director | 14-Jan-1999 | Current |
| Sobana Balakrishnan | Director | 14-Jan-1999 | Current |
| Kootala Balakrishnan | Director | 14-Jan-1999 | Current |
Financial Performance of Dr.Sarma`S Laboratories.
Dr.Sarma`S Laboratories Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dr.Sarma`S Laboratories?
In 2017, Dr.Sarma`S Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹0.15 M
Charges Breakdown by Lending Institutions
- United Bank Of India : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Oct 2000 | United Bank Of India | ₹0.15 M | Satisfied |
How Many Employees Work at Dr.Sarma`S Laboratories?
Unlock and access historical data on people associated with Dr.Sarma`S Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr.Sarma`S Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.Sarma`S Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
